GEOFFREY M DUYK Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GEOFFREY M DUYK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GEOFFREY M DUYK. GEOFFREY M DUYK is Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Director in AERIE PHARMACEUTICALS INC ($AERI) and Director in AMYRIS, INC. ($AMRS).
Latest Insider Trading Transactions of GEOFFREY M DUYK
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AERI, AMRS, CRXX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 07 2020 | AMRS | AMYRIS, INC. | DUYK GEOFFREY M | Director | Option Exercise | A | 4.94 | 3,466 | 17,122 | 3,466 | |
Aug 07 2020 | AMRS | AMYRIS, INC. | DUYK GEOFFREY M | Director | Grant | A | 0.00 | 9,566 | 0 | 23,398 | 13.8 K to 23.4 K (+69.16 %) |
Oct 25 2019 | AMRS | AMYRIS, INC. | DUYK GEOFFREY M | Director | Option Exercise | A | 3.73 | 3,466 | 12,928 | 3,466 | |
Oct 25 2019 | AMRS | AMYRIS, INC. | DUYK GEOFFREY M | Director | Option Exercise | A | 3.73 | 3,466 | 12,928 | 3,466 | |
Oct 25 2019 | AMRS | AMYRIS, INC. | DUYK GEOFFREY M | Director | Grant | A | 0.00 | 9,566 | 0 | 13,832 | 4.3 K to 13.8 K (+224.24 %) |
Oct 25 2019 | AMRS | AMYRIS, INC. | DUYK GEOFFREY M | Director | Grant | A | 0.00 | 9,566 | 0 | 13,832 | 4.3 K to 13.8 K (+224.24 %) |
Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Option Exercise | M | 3.15 | 28,000 | 88,200 | 0 | |
Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Option Exercise | M | 17.55 | 13,500 | 236,925 | 0 | |
Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Option Exercise | M | 32.30 | 10,000 | 323,000 | 0 | |
Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Option Exercise | M | 19.50 | 6,667 | 130,007 | 3,333 | |
Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Sell | S | 46.81 | 20,796 | 973,438 | 3,400 | 24.2 K to 3.4 K (-85.95 %) |
Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Sell | S | 46.46 | 20,795 | 966,059 | 24,196 | 45 K to 24.2 K (-46.22 %) |
Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Payment of Exercise | F | 46.95 | 1,879 | 88,219 | 44,991 | 46.9 K to 45 K (-4.01 %) |
Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Buy | M | 3.15 | 28,000 | 88,200 | 46,870 | 18.9 K to 46.9 K (+148.38 %) |
Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Payment of Exercise | F | 46.95 | 5,047 | 236,957 | 18,870 | 23.9 K to 18.9 K (-21.10 %) |
Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Buy | M | 17.55 | 13,500 | 236,925 | 23,917 | 10.4 K to 23.9 K (+129.60 %) |
Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Payment of Exercise | F | 46.95 | 6,880 | 323,016 | 10,417 | 17.3 K to 10.4 K (-39.78 %) |
Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Buy | M | 32.30 | 10,000 | 323,000 | 17,297 | 7.3 K to 17.3 K (+137.04 %) |
Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Payment of Exercise | F | 46.95 | 2,770 | 130,052 | 7,297 | 10.1 K to 7.3 K (-27.52 %) |
Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Buy | M | 19.50 | 6,667 | 130,007 | 10,067 | 3.4 K to 10.1 K (+196.09 %) |
Nov 07 2016 | AMRS | AMYRIS, INC. | DUYK GEOFFREY M | Director | Grant | A | 0.00 | 35,000 | 0 | 64,000 | 29 K to 64 K (+120.69 %) |
Jul 15 2016 | AMRS | AMYRIS, INC. | DUYK GEOFFREY M | Director | Option Exercise | A | 0.41 | 26,000 | 10,660 | 26,000 | |
Jul 15 2016 | AMRS | AMYRIS, INC. | DUYK GEOFFREY M | Director | Grant | A | 0.00 | 17,000 | 0 | 29,000 | 12 K to 29 K (+141.67 %) |
Jun 09 2016 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Option Exercise | A | 19.50 | 10,000 | 195,000 | 10,000 | |
Jun 09 2016 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Grant | A | 0.00 | 1,700 | 0 | 3,400 | 1.7 K to 3.4 K (+100.00 %) |
Aug 03 2015 | AMRS | AMYRIS, INC. | DUYK GEOFFREY M | Director | Option Exercise | A | 1.69 | 6,000 | 10,140 | 6,000 | |
Aug 03 2015 | AMRS | AMYRIS, INC. | DUYK GEOFFREY M | Director | Grant | A | 0.00 | 3,000 | 0 | 12,000 | 9 K to 12 K (+33.33 %) |
Jun 08 2015 | CRXX | EPIRUS Biopharmace ... | DUYK GEOFFREY M | Director | Option Exercise | A | 6.39 | 9,000 | 57,510 | 9,000 | |
Apr 14 2015 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Option Exercise | A | 32.30 | 10,000 | 323,000 | 10,000 | |
Apr 14 2015 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Grant | A | 0.00 | 1,700 | 0 | 1,700 | 0 to 1.7 K |
Page: 1